nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—trigeminal nucleus—multiple sclerosis	0.251	0.403	CbGeAlD
Cinitapride—HTR2A—trigeminal nerve—multiple sclerosis	0.0659	0.106	CbGeAlD
Cinitapride—HTR2A—pons—multiple sclerosis	0.0464	0.0746	CbGeAlD
Cinitapride—HTR4—brain—multiple sclerosis	0.038	0.061	CbGeAlD
Cinitapride—HTR2A—pineal body—multiple sclerosis	0.0331	0.0532	CbGeAlD
Cinitapride—HTR2A—peripheral nervous system—multiple sclerosis	0.0309	0.0496	CbGeAlD
Cinitapride—HTR2A—nerve—multiple sclerosis	0.0241	0.0387	CbGeAlD
Cinitapride—HTR1A—brainstem—multiple sclerosis	0.0173	0.0279	CbGeAlD
Cinitapride—HTR1A—midbrain—multiple sclerosis	0.0111	0.0178	CbGeAlD
Cinitapride—HTR1A—spinal cord—multiple sclerosis	0.0108	0.0173	CbGeAlD
Cinitapride—HTR2A—brainstem—multiple sclerosis	0.0103	0.0166	CbGeAlD
Cinitapride—HTR2A—retina—multiple sclerosis	0.00997	0.016	CbGeAlD
Cinitapride—HTR1A—nervous system—multiple sclerosis	0.00909	0.0146	CbGeAlD
Cinitapride—HTR1A—central nervous system—multiple sclerosis	0.00875	0.0141	CbGeAlD
Cinitapride—HTR1A—cerebellum—multiple sclerosis	0.00855	0.0137	CbGeAlD
Cinitapride—HTR2A—medulla oblongata—multiple sclerosis	0.00721	0.0116	CbGeAlD
Cinitapride—HTR1A—brain—multiple sclerosis	0.00695	0.0112	CbGeAlD
Cinitapride—HTR2A—midbrain—multiple sclerosis	0.00659	0.0106	CbGeAlD
Cinitapride—HTR2A—spinal cord—multiple sclerosis	0.00643	0.0103	CbGeAlD
Cinitapride—HTR2A—nervous system—multiple sclerosis	0.00542	0.0087	CbGeAlD
Cinitapride—HTR2A—central nervous system—multiple sclerosis	0.00521	0.00838	CbGeAlD
Cinitapride—HTR2A—cerebellum—multiple sclerosis	0.0051	0.00819	CbGeAlD
Cinitapride—HTR2A—brain—multiple sclerosis	0.00414	0.00665	CbGeAlD
Cinitapride—HTR1A—GPCR ligand binding—CCR1—multiple sclerosis	0.00116	0.00307	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CXCL13—multiple sclerosis	0.00116	0.00307	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—CCL2—multiple sclerosis	0.00116	0.00306	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00114	0.00303	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—CNR1—multiple sclerosis	0.00114	0.00301	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CNR1—multiple sclerosis	0.00111	0.00294	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CXCL13—multiple sclerosis	0.0011	0.00292	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCR1—multiple sclerosis	0.0011	0.00292	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.0011	0.00292	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—CXCL10—multiple sclerosis	0.0011	0.00292	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—GPR65—multiple sclerosis	0.00109	0.0029	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00108	0.00287	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00106	0.0028	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00105	0.00279	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00105	0.00279	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00104	0.00276	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.00102	0.00271	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00102	0.00269	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00101	0.00267	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCR1—multiple sclerosis	0.001	0.00265	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CXCL13—multiple sclerosis	0.001	0.00265	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CXCL10—multiple sclerosis	0.001	0.00265	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000988	0.00262	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00098	0.0026	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—CCL5—multiple sclerosis	0.000948	0.00251	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000936	0.00248	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000912	0.00242	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000905	0.0024	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000901	0.00239	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000888	0.00235	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000882	0.00234	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000871	0.00231	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CCL5—multiple sclerosis	0.000861	0.00228	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—CCR5—multiple sclerosis	0.000854	0.00226	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000847	0.00224	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000842	0.00223	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCL3—multiple sclerosis	0.000825	0.00219	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000814	0.00216	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—S1PR1—multiple sclerosis	0.000806	0.00214	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—PTGER4—multiple sclerosis	0.000795	0.0021	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000794	0.0021	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCL3—multiple sclerosis	0.000786	0.00208	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000782	0.00207	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CCR5—multiple sclerosis	0.000776	0.00205	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CXCR3—multiple sclerosis	0.000767	0.00203	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000767	0.00203	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL2RA—multiple sclerosis	0.000764	0.00202	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PTGER4—multiple sclerosis	0.000757	0.002	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000755	0.002	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCR2—multiple sclerosis	0.000746	0.00198	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PGR—multiple sclerosis	0.000745	0.00197	CbGpPWpGaD
Cinitapride—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000737	0.00195	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CXCR3—multiple sclerosis	0.000731	0.00194	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CD28—multiple sclerosis	0.000724	0.00192	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000716	0.0019	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCL3—multiple sclerosis	0.000713	0.00189	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCR2—multiple sclerosis	0.000711	0.00188	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000704	0.00186	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000701	0.00186	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—S1PR1—multiple sclerosis	0.000697	0.00185	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CNR1—multiple sclerosis	0.000689	0.00182	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—PTGER4—multiple sclerosis	0.000686	0.00182	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—RGS1—multiple sclerosis	0.000686	0.00182	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—POMC—multiple sclerosis	0.000668	0.00177	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CXCR3—multiple sclerosis	0.000663	0.00176	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CNR1—multiple sclerosis	0.000656	0.00174	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000655	0.00173	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000655	0.00173	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000652	0.00173	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GPR65—multiple sclerosis	0.00065	0.00172	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCR2—multiple sclerosis	0.000645	0.00171	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000639	0.00169	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000637	0.00169	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000632	0.00167	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LINGO1—multiple sclerosis	0.000629	0.00166	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—POMC—multiple sclerosis	0.000621	0.00164	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CXCL10—multiple sclerosis	0.00062	0.00164	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000618	0.00164	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—POMC—multiple sclerosis	0.000606	0.00161	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000606	0.0016	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CNR1—multiple sclerosis	0.000595	0.00158	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000594	0.00157	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCR1—multiple sclerosis	0.000594	0.00157	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CCL2—multiple sclerosis	0.000593	0.00157	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—RGS1—multiple sclerosis	0.000592	0.00157	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CXCL10—multiple sclerosis	0.000591	0.00156	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000566	0.0015	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000566	0.0015	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GPR65—multiple sclerosis	0.000562	0.00149	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000552	0.00146	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000546	0.00145	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TAGAP—multiple sclerosis	0.000545	0.00144	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LINGO1—multiple sclerosis	0.000543	0.00144	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—TYK2—multiple sclerosis	0.000539	0.00143	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000536	0.00142	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCL5—multiple sclerosis	0.000534	0.00141	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CD86—multiple sclerosis	0.000517	0.00137	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCR1—multiple sclerosis	0.000514	0.00136	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000514	0.00136	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000512	0.00136	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCL5—multiple sclerosis	0.000509	0.00135	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000494	0.00131	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—IL2—multiple sclerosis	0.000493	0.00131	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000483	0.00128	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCR5—multiple sclerosis	0.000481	0.00127	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—S1PR1—multiple sclerosis	0.000476	0.00126	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SPP1—multiple sclerosis	0.000471	0.00125	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TAGAP—multiple sclerosis	0.000471	0.00125	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000464	0.00123	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GPC5—multiple sclerosis	0.000463	0.00123	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCL5—multiple sclerosis	0.000461	0.00122	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCR5—multiple sclerosis	0.000458	0.00121	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL2RA—multiple sclerosis	0.000452	0.0012	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000449	0.00119	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL2—multiple sclerosis	0.000448	0.00119	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000434	0.00115	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000426	0.00113	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCL3—multiple sclerosis	0.000424	0.00112	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000422	0.00112	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000417	0.00111	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—APOE—multiple sclerosis	0.000417	0.0011	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCR5—multiple sclerosis	0.000416	0.0011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—S1PR1—multiple sclerosis	0.000412	0.00109	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000408	0.00108	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RGS1—multiple sclerosis	0.000405	0.00107	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000401	0.00106	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GPC5—multiple sclerosis	0.0004	0.00106	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000394	0.00104	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000389	0.00103	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000388	0.00103	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GPR65—multiple sclerosis	0.000384	0.00102	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCR2—multiple sclerosis	0.000383	0.00101	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CD80—multiple sclerosis	0.000377	0.000998	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—POMC—multiple sclerosis	0.000376	0.000996	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000375	0.000992	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000374	0.000992	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCL2—multiple sclerosis	0.000368	0.000974	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL3—multiple sclerosis	0.000366	0.000969	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000364	0.000965	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—POMC—multiple sclerosis	0.000358	0.000948	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CNR1—multiple sclerosis	0.000354	0.000936	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000352	0.000933	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCR1—multiple sclerosis	0.000351	0.00093	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL13—multiple sclerosis	0.000351	0.00093	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000351	0.000928	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCL2—multiple sclerosis	0.00035	0.000928	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RGS1—multiple sclerosis	0.00035	0.000927	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—MAPK1—multiple sclerosis	0.000343	0.000908	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCR3—multiple sclerosis	0.00034	0.000901	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000336	0.000891	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GPR65—multiple sclerosis	0.000332	0.000879	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCR2—multiple sclerosis	0.000331	0.000877	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000326	0.000863	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—POMC—multiple sclerosis	0.000325	0.00086	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000323	0.000857	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000318	0.000843	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TYK2—multiple sclerosis	0.000318	0.000843	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCL2—multiple sclerosis	0.000318	0.000842	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CNR1—multiple sclerosis	0.000305	0.000809	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL13—multiple sclerosis	0.000303	0.000804	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR1—multiple sclerosis	0.000303	0.000804	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000303	0.000802	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000302	0.000799	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000275	0.000728	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	0.000274	0.000726	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000272	0.00072	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000268	0.00071	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL2—multiple sclerosis	0.000265	0.000701	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL6—multiple sclerosis	0.000263	0.000698	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000261	0.00069	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MMP9—multiple sclerosis	0.000251	0.000664	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00025	0.000663	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	0.00025	0.000663	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	0.000247	0.000654	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000243	0.000644	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	0.000241	0.000638	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PGR—multiple sclerosis	0.000237	0.000628	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	0.000237	0.000627	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000235	0.000622	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	0.000233	0.000616	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000231	0.000613	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CD28—multiple sclerosis	0.00023	0.00061	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	0.000226	0.000599	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—STAT3—multiple sclerosis	0.000223	0.00059	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	0.000216	0.000573	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	0.000213	0.000565	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	0.000212	0.000563	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	0.00021	0.000557	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	0.000209	0.000553	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	0.000208	0.000551	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MYC—multiple sclerosis	0.000207	0.000548	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TGFB1—multiple sclerosis	0.000206	0.000547	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PGR—multiple sclerosis	0.000205	0.000543	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MAPK1—multiple sclerosis	0.000203	0.000536	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	0.000201	0.000532	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CD28—multiple sclerosis	0.000199	0.000527	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	0.000195	0.000518	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	0.000193	0.000511	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	0.000189	0.0005	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	0.000188	0.000498	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	0.000184	0.000486	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	0.00018	0.000478	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	0.000171	0.000454	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	0.000167	0.000441	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CD86—multiple sclerosis	0.000164	0.000436	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	0.000163	0.000432	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	0.000162	0.00043	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	0.000162	0.000429	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	0.000157	0.000416	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6—multiple sclerosis	0.000156	0.000412	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	0.00015	0.000397	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	0.000148	0.000392	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	0.000146	0.000386	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	0.000144	0.000381	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	0.000143	0.000378	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CD86—multiple sclerosis	0.000142	0.000376	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	0.00014	0.00037	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	0.000136	0.000359	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOE—multiple sclerosis	0.000133	0.000351	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	0.00013	0.000343	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	0.000126	0.000334	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	0.000124	0.000329	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	0.000123	0.000326	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CD80—multiple sclerosis	0.00012	0.000318	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOE—multiple sclerosis	0.000115	0.000304	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—POMC—multiple sclerosis	0.000114	0.000302	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	0.000112	0.000295	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000109	0.000289	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CD80—multiple sclerosis	0.000104	0.000274	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	0.000101	0.000268	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—POMC—multiple sclerosis	9.85e-05	0.000261	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	9.63e-05	0.000255	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	9.43e-05	0.00025	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	8.75e-05	0.000232	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL2—multiple sclerosis	8.43e-05	0.000223	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	8.38e-05	0.000222	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	7.97e-05	0.000211	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL2—multiple sclerosis	7.28e-05	0.000193	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	7.24e-05	0.000192	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	7.09e-05	0.000188	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	6.89e-05	0.000182	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MYC—multiple sclerosis	6.59e-05	0.000174	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	6.57e-05	0.000174	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	6.44e-05	0.000171	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	6.12e-05	0.000162	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MYC—multiple sclerosis	5.69e-05	0.000151	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	5.68e-05	0.00015	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	5.57e-05	0.000147	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6—multiple sclerosis	4.95e-05	0.000131	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6—multiple sclerosis	4.28e-05	0.000113	CbGpPWpGaD
